S.2478: End Taxpayer Subsidies for Drug Ads Act

About This Bill

Bill Cosponsors

3 (2 Democrats, 1 Independent Democrat)

Bill Version

Bill Summary

End Taxpayer Subsidies for Drug Ads Act This bill amends the Internal Revenue Code to prohibit tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs. "Direct-to-consumer advertising" is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is: (1) in regard to the drug product, and (2) primarily targeted to the general public.

(Source: Library of Congress)

Bill Actions

Date Description
March 1, 2018
Read twice and referred to the Committee on Finance.
March 1, 2018

Introduced in the Senate by Claire McCaskill (D-Mo.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page